Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retraction Notice to: Corrigendum to "Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders".
Javed H, Menon SA, Al-Mansoori KM, Al-Wandi A, Majbour NK, Ardah MT, Varghese S, Vaikath NN, Haque ME, Azzouz M, El-Agnaf OM. Javed H, et al. Among authors: el agnaf om. Mol Ther. 2024 Apr 11:S1525-0016(24)00233-8. doi: 10.1016/j.ymthe.2024.04.016. Online ahead of print. Mol Ther. 2024. PMID: 38608701 No abstract available.
Retraction Notice to: Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders.
Javed H, Menon SA, Al-Mansoori KM, Al-Wandi A, Majbour NK, Ardah MT, Varghese S, Vaikath NN, Haque ME, Azzouz M, El-Agnaf OM. Javed H, et al. Among authors: el agnaf om. Mol Ther. 2024 Apr 11:S1525-0016(24)00232-6. doi: 10.1016/j.ymthe.2024.04.015. Online ahead of print. Mol Ther. 2024. PMID: 38608700 No abstract available.
Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study.
Al-Akl NS, Khalifa O, Ponirakis G, Parray A, Ramadan M, Khan S, Chandran M, Ayadathil R, Elsotouhy A, Own A, Al Hamad H, Decock J, Alajez NM, Albagha O, Malik RA, El-Agnaf OMA, Arredouani A. Al-Akl NS, et al. Among authors: el agnaf oma. Int J Mol Sci. 2024 Feb 13;25(4):2247. doi: 10.3390/ijms25042247. Int J Mol Sci. 2024. PMID: 38396924 Free PMC article.
Corrigendum to " Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy Body Disease" [Neurobiology of Disease127 (2019) 163-177].
Spencer B, Trinh I, Rockenstein E, Mante M, Florio J, Adame A, El-Agnaf OMA, Kim C, Masliah E, Rissman RA. Spencer B, et al. Among authors: el agnaf oma. Neurobiol Dis. 2024 Feb;191:106397. doi: 10.1016/j.nbd.2023.106397. Epub 2024 Jan 12. Neurobiol Dis. 2024. PMID: 38216383 Free article. No abstract available.
Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia.
Ehtewish H, Mesleh A, Ponirakis G, Lennard K, Al Hamad H, Chandran M, Parray A, Abdesselem H, Wijten P, Decock J, Alajez NM, Ramadan M, Khan S, Ayadathil R, Own A, Elsotouhy A, Albagha O, Arredouani A, Blackburn JM, Malik RA, El-Agnaf OMA. Ehtewish H, et al. Among authors: el agnaf oma. Front Neurol. 2023 Nov 30;14:1256745. doi: 10.3389/fneur.2023.1256745. eCollection 2023. Front Neurol. 2023. PMID: 38107644 Free PMC article.
179 results